Example: Heart Attack

Search clinical trials for: 68Ga-FAPI-RGD

Total 2493 results

NCT05073653

Recruiting

A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer

Prostate Cancer
NCT05806853

Completed

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

Prostate Cancer
NCT04452136

Approved for marketing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic
NCT03762759

Active, not recruiting

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Prostate Adenocarcinoma
NCT05810246

Recruiting

68Ga-NY104 PET/CT in Von Hippel-Lindau Disease

Von Hippel-Lindau Disease
NCT06327386

Recruiting

The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer

Cancer
NCT02812264

Completed

Using an API to Commercialize an Evidence-Based Weight Loss Intervention

Weight Loss | Health Behavior
NCT07608848

Recruiting

First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer (DOTA-STR-17126)

Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Theranostic | Active Cancer | GRPR-Targeted Molecular Imaging | Theranostic Radiopharmaceuticals | Radiopharmaceutical
NCT07219238

Recruiting

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Colorectal Cancer | Pancreatic Ductal Adenocarcinoma | Gastric Cancers | Ovarian Cancers
NCT06519760

Recruiting

68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma | PET-CT | Carbonic Anhydrase IX
NCT06148220

Recruiting

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Kidney Cancer | Positron Emission Tomography | Lymphomas
NCT06147362

Recruiting

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

Cancer
NCT02931929

Completed

MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT

Gastrointestinal Stromal Tumors
NCT06503146

Recruiting

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Sarcoma | Hepatocellular Carcinoma | Gastric Cancer | Ovarian Cancer | Mesothelioma | Cholangiocarcinoma | Bladder Cancer | Pancreatic Ductal Adenocarcinoma | Pheochromocytoma/Paraganglioma (PPGL) | Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)
NCT06500065

Recruiting

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

Soft Tissue Sarcoma
NCT04156893

Recruiting

RH Genotype Matched RBC Transfusions (RBC)

Sickle Cells Disease
NCT07593976

Not yet recruiting

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer (GATHER)

Breast Cancer
NCT07301801

Recruiting

Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors

Malignant Tumors | PET | SSTR2
NCT07288931

Recruiting

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

Pheochromocytoma/Paraganglioma (PPGL)
NCT06690957

Recruiting

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

Metastasis | Tumor | Positron Emission Tomography | SSTR-related Disease
NCT06203613

Recruiting

Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer

Pancreatic Neoplasms | Positron Emission Tomography | Igestive System Neoplasms
NCT05889728

Recruiting

Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer

Breast Cancer
NCT06759740

Withdrawn

An Exploratory Study of 68Ga-DOTA-SEMA in Preoperative Precise Imaging of Patients with Glucagon-Like Peptide-1 Receptor (GLP1R) Positive Insulinomas

Hypoglycaemia
NCT03755245

Enrolling by invitation

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis (SIGLEC)

Rheumatoid Arthritis | Vasculitis | Healthy Subjects | Pulmonary Sarcoidosis
NCT01396382

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer (68Ga)

Neuroendocrine Carcinoma
NCT03606837

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging (PROSTATEP)

Prostate Cancer
NCT06506097

Recruiting

Family-school Partnership Intervention for Early Childhood Education

Autism Spectrum Disorder
NCT06696326

Recruiting

A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer

Prostate Cancer | Positron-Emission Tomography(PET) | Trophoblast Cell Surface Antigen 2
NCT00652080

Completed

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

Squamous Cell Carcinoma
NCT07621146

Not yet recruiting

A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies (NET-COMPARE)

Medullary Thyroid Carcinoma | Pheochromocytoma/Paraganglioma | Neuroendocrine Tumors, NET | SSTR-expressing Tumors
NCT06203574

Recruiting

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Neoplasms | Positron-Emission Tomography
NCT05228106

Recruiting

68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

Solid Cancers
NCT04831307

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease
NCT03393689

Unknown

RGD PET/MRI in Sporadic Vestibular Schwannoma

Acoustic Neuroma
NCT06318234

Recruiting

PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer

Rectal Cancer
NCT05432947

Completed

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Clear Cell Renal Cell Carcinoma
NCT03604757

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer
NCT06062342

Recruiting

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities (FPI)

Hiv
NCT07508852

Recruiting

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

Small Cell Lung Cancer | SCLC | SCLC, Extensive Stage | SCLC, Limited Stage | Small Cell Lung Cancer ( SCLC )
NCT07022080

Not yet recruiting

Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease

Inflammatory Bowel Diseases (IBD)
NCT06770478

Recruiting

A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours

Tumour of Epithelial Origin | 68Ga-MY6349
NCT05841992

Recruiting

Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

Prostate Cancer
NCT07589101

Not yet recruiting

5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Breast Cancer | Lung Cancer
NCT06828588

Recruiting

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Metastatic Cancer | Locally Advanced Cancer | HER2 | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER 2 Low-expressing Breast Cancer
NCT05977322

Terminated

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Glioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma
NCT02485886

Unknown

68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
NCT06402331

Active, not recruiting

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (AlphaBreak)

Metastatic Castration-resistant Prostate Cancer
NCT04595071

Completed

Functional Outcomes of Voice Recognition Prosthesis

Amputation | Prosthesis | Prosthesis User
NCT00604890

Completed

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

Superficial Basal Cell Carcinoma
NCT05363605

Terminated

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Breast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Liver Cancer | Bladder Carcinoma | Susceptible FGFR3 Genetic Alterations

Search clinical trials for: 68Ga-FAPI-RGD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations